Multi-layer platform coordination for open innovation in oligonucleotide therapeutics

•The oligonucleotide therapeutics market has evolved through open innovation.•The pharmaceutical industry is moving from vertical integration to horizontal specialization.•Biotechnology firms provide platforms for the R&D of new drugs and technologies.•Pharmaceutical firms provide platforms for...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Drug discovery today 2025-01, Vol.30 (2), p.104288, Article 104288
Hauptverfasser:	Kawata, Yayoi, Ichimaru, Taisuke, Kogami, Masakazu, Kodama, Kota, Miyashita, Shuto, Sengoku, Shintaro
Format:	Artikel
Sprache:	eng
Schlagworte:	biopharmaceutical oligonucleotide therapeutics open innovation platform leadership technological transition
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!